Ryr2tm3.1Maya
Targeted Allele Detail
|
|
| Symbol: |
Ryr2tm3.1Maya |
| Name: |
ryanodine receptor 2, cardiac; targeted mutation 3.1, Masafumi Yano |
| MGI ID: |
MGI:6782402 |
| Synonyms: |
V3599K-KI |
| Gene: |
Ryr2 Location: Chr13:11567988-12121831 bp, - strand Genetic Position: Chr13, 4.38 cM, cytoband A1-A2
|
| Alliance: |
Ryr2tm3.1Maya page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:308964
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
C57BL/6
|
|
| Allele Type: |
|
Targeted (Not Applicable) |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details: A mutation was engineered in exon 76 to change valine codon 3598 to a lysine codon (p.V3598K) and a loxP site flanked neomycin resistance gene cassette was inserted into intron 76. The neo cassette was removed through subsequent cre-mediated recombination. The mutation in the calmodulin (CaM) binding domain significantly increases binding affinity of the encoded peptide to calmodulin.
(J:308964)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Ryr2 Mutation: |
330 strains or lines available
|
|
| Original: |
J:308964 Nakamura Y, et al., Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia. JCI Insight. 2019 Jun 6;4(11) |
| All: |
1 reference(s) |
|